Shandong Buchang Pharmaceuticals (SHA:603858) said subsidiary Changrui Biotechnology completed its industrial and commercial registration.
The subsidiary has obtained the business license reissued by the Chengdu High-tech Industrial Development Zone Market Supervision and Administration Bureau, according to a Friday filing with the Shanghai bourse.
Shares of the pharmaceutical company rose 2% Friday.